Currency fall benefits Drager
This article was originally published in Clinica
Executive Summary
While Dragerwerk saw its German business shrink by nearly 5% in 1997, its foreign sales more than compensated - jumping 17%. Worldwide sales of medical technology grew 7.7% to DM1.07 billion ($605 million), accounting for 63% of the group's total turnover of DM1.69 billion (+7.9%).
You may also be interested in...
Prestige Expands UK Eye Care Range In Response To Consumer Demand
A “great consumer response” to TheraTears in the UK leads Prestige Consumer Healthcare to add TheraTears 5-in-1 Irritation and Redness eye drops to the range.
Who’s Hired? Hikma Recruits New US Generics President
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.
Organon And Henlius Complete Phase III For Denosumab
Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.